Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126010691 | 12601069 | 1 | I | 20160718 | 20160728 | 20160728 | EXP | GB-ROCHE-1801733 | ROCHE | 63.00 | YR | M | Y | 0.00000 | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126010691 | 12601069 | 1 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | 0 | ||||||||||
| 126010691 | 12601069 | 2 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125085 | ||||||||||
| 126010691 | 12601069 | 3 | SS | XGEVA | DENOSUMAB | 1 | Subcutaneous | U | 0 | SOLUTION FOR INJECTION | |||||||||
| 126010691 | 12601069 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 126010691 | 12601069 | 5 | C | PREGABALIN. | PREGABALIN | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 6 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 7 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 8 | C | FORCEVAL | FOLIC ACIDIRONMINERALSVITAMINS | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 10 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 11 | C | THIAMINE. | THIAMINE | 1 | 0 | ||||||||||||
| 126010691 | 12601069 | 12 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126010691 | 12601069 | 1 | Product used for unknown indication |
| 126010691 | 12601069 | 2 | Product used for unknown indication |
| 126010691 | 12601069 | 3 | Product used for unknown indication |
| 126010691 | 12601069 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126010691 | 12601069 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126010691 | 12601069 | Alopecia | |
| 126010691 | 12601069 | Arthralgia | |
| 126010691 | 12601069 | Chronic obstructive pulmonary disease | |
| 126010691 | 12601069 | Dyspnoea exertional | |
| 126010691 | 12601069 | Failure to anastomose | |
| 126010691 | 12601069 | Insomnia | |
| 126010691 | 12601069 | Neuropathy peripheral | |
| 126010691 | 12601069 | Skin ulcer | |
| 126010691 | 12601069 | Spinal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |